<DOC>
	<DOCNO>NCT02623569</DOCNO>
	<brief_summary>Arms Assigned Interventions Experimental : Ivabradine Ivabradine 5 mg twice day first 4 week 7.5mg twice day positive ETT HR＞60times/min negative ETT HR＞80times/min subject . Active Comparator : Atenolol Atenolol 12.5 mg twice day first 4 week 25mg twice day positive ETT hear rate＞60times/min negative ETT HR ＞80times/min subject .</brief_summary>
	<brief_title>To Assess Anti-anginal Safety Efficacy Ivabradine Subjects With Stable，Symptomatic Chronic Angina</brief_title>
	<detailed_description>1 . Washout period：Chronic angina patient stop use medicine affect heart rate . The patient undergoes ETT 2-7 day positive ETT treatment period ( If take similar medicine , patient carry ETT directly ) 。 2 . Treatment period：Patients carry ETT therapy Ivabradine ( 5mg , bid ) / Atenolol ( 12.5mg , bid ) 4 weeks.The dose adjust base test result heart rate , Ivabradine ( 5mg , bid ) /Atenolol ( 12.5mg , bid ) Ivabradine ( 7.5mg , bid ) / Atenolol ( 25mg , bid ) 8 week carry ETT . 3. security period：After treatment period , patient take Atenolol 12.5mg/ 25mg bid 1 week . If heart rate low 50 times/min take Ivabradine 5mg/ Atenolol 12.5mg , subject withdrawal drop study . If subject heart rate low 50 times/min take Ivabradine 7.5mg/ Atenolol 25mg , subject change dose Ivabradine 5mg/ Atenolol 12.5mg .</detailed_description>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<criteria>1. male female age 18 75 year 2 . Clearly understand study participate voluntarily ; inform consent sign person legal guardian . 3 . Chronic Stable Angina confirm clinic 3 month . 4 . Patients clinical diagnosis chronic stable angina must meet one follow condition : Patients history myocardial infarction 3 month . Patients receive coronary intervention CABG（Coronary Artery Bypass Grafting） 6 month . Stenosis 50 % least one major epicardial coronary artery show Coronary Angiograph . Ischemic electrocardiogram changes：STsegment depression ≥ 1.0 mm compare PR elevate≥1.0 mm exercise ECG Computed Tomography Angiography ( CTA ) show 50 % stenosis typical angina symptom 5. ultrasonic cardiogram disclose leave ventricular ejection fraction ≥50 % . 6 . Patients manifest positive ETT ( exercise tolerance test ) ( define STsegment depression ≥ 1 mm compare rest , without limit angina ) screening . 1 . Clinically significant Valvular disease , congenital heart disease , pulmonary hypertension , cerebral apoplexy , dissect aneurysm , hypertrophic cardiomyopathy , acute myocarditis/cp . 2 . Patients myocardial infarction within precede 3 month 3 . Patients receive Coronary angioplasty CABG within precede 6 month . 4 . Patients severity vessel disease leave main coronary artery valid treatment . 5 . Patients congestive heart failure ( New York Heart Association class III IV ) acute pulmonary edema . 6 . Patients whose rest heart rate &lt; 60 bpm . 7 . Patients nonrespiratory sinus arrhythmia arrhythmia ( e.g. , AVB ( auriculoventricular block ) ⅡⅢ , atrial fibrillation , atrial flutter , SSS ( sick sinus syndrome ) ) implantable cardiac defibrillator ( ICD ) . 8 . Patient condition interfere performance exercise tolerance test history abnormal exercise response limit electrocardiograph ( ECG ) change . 9 . Patient uncontrolled hypertension ( seat systolic blood pressure ( SBP）≥180 mmHg diastolic blood pressure ( DBP ) ≥100 mmHg ) ; SBP &lt; 90 mmHg and/or DBP &lt; 60 mmHg 10 . Diabetic uncontrolled blood glucose ( FBG≥11.1 mmol/L and/or RBG≥13.6 mmol/L） 11 . Patients anemia ( male : Hb≤120 g/L；female：Hb≤110 g/L ) 12 . Patients complicate systemic disease include thyroid dysfunction、glaucoma、cataract，neurological、mental、psychological disease disease influence judgment . 13 . Severe concurrent pathology , include terminal illness ( cancer , AIDS , etc. ) . 14 . Patients mental legal disorder . 15 . Patients suspect addicted alcohol drug abuse severe complication would make condition complicate assessed investigator . 16 . People liver renal dysfunction ( ALT≥2×ULN、AST≥2×ULN、eGFR≤60ml/min/1.73m2） 17 . Patients use unapproved drug study . 18 . Patients accept amiodarone ( recent 3 month ) and/or benzetimide、βblockers（in recent 7 day ) 、 19 . Patients history allergy suspect allergic drug（e.g.，Hydrochloric ivabradine , atenolol , βblockers）or lactose . 20 . Woman disagree contraception treatment period ，with pregnancy , lactation positive result pregnancy test . 21 . Patients Chronic Obstructive Pulmonary Disease ( COPD ) require bronchodilator . 22 . Patients participate trial participate trial recent 3 month 23 . Patients unable participate study judge investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>